77 related articles for article (PubMed ID: 3360570)
21. Prognostic value of breast cancer subtypes on breast cancer specific survival, distant metastases and local relapse rates in conservatively managed early stage breast cancer: a retrospective clinical study.
Sanpaolo P; Barbieri V; Genovesi D
Eur J Surg Oncol; 2011 Oct; 37(10):876-82. PubMed ID: 21824742
[TBL] [Abstract][Full Text] [Related]
22. [Sequential study of the immunologic picture in neoplasm patients before and after surgical intervention].
Albertino B; Borgialli R; Guerra MG; Gasparri G; Oliaro A; Dei Poli M
Minerva Chir; 1989 Sep; 44(17):1917-20. PubMed ID: 2531304
[TBL] [Abstract][Full Text] [Related]
23. [Thymopentin and immune response in patients with cancer].
Petronella P; Ferrone R; Freda F; Valeriani G
Minerva Chir; 1989 Sep; 44(18):2017-20. PubMed ID: 2694011
[TBL] [Abstract][Full Text] [Related]
24. [Stimulation of the immunological reactivity of cancer patients by Eleutherococcus extract].
Kupin VI; Polevaia EB
Vopr Onkol; 1986; 32(7):21-6. PubMed ID: 3526720
[TBL] [Abstract][Full Text] [Related]
25. Lymphocyte response to PHA and patient response to chemotherapy in breast cancer.
Jones KD; Whitehead RH; Grimshaw D; Hughes LE
Clin Oncol; 1980 Jun; 6(2):159-66. PubMed ID: 7408283
[No Abstract] [Full Text] [Related]
26. 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S; Catena F; Santini D; Ansaloni L; Fogacci T; Mignani S; Leone A; Gazzotti F; Gagliardi S; De Cataldis A; Taffurelli M
Breast Cancer Res Treat; 2008 Jun; 109(3):405-16. PubMed ID: 17687650
[TBL] [Abstract][Full Text] [Related]
27. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
28. [Individualization of polychemotherapy for stage III breast cancer based on immunologic status].
Sabala PI
Vopr Onkol; 1984; 30(11):44-8. PubMed ID: 6516259
[TBL] [Abstract][Full Text] [Related]
29. Generation of immunity to the HER-2/neu oncogenic protein in patients with breast and ovarian cancer using a peptide-based vaccine.
Disis ML; Grabstein KH; Sleath PR; Cheever MA
Clin Cancer Res; 1999 Jun; 5(6):1289-97. PubMed ID: 10389911
[TBL] [Abstract][Full Text] [Related]
30. HLA antigen as predictive index for the outcome of breast cancer patients with adjuvant immunochemotherapy with PSK.
Yokoe T; Iino Y; Takei H; Horiguchi J; Koibuchi Y; Maemura M; Ohwada S; Morishita Y
Anticancer Res; 1997; 17(4A):2815-8. PubMed ID: 9252721
[TBL] [Abstract][Full Text] [Related]
31. [Intact cellular immune response in patients with locally metastasizing breast carcinoma at the time of diagnosis].
Ludwig C; Hartmann D; Landmann R; Wesp M; Rosenfelder G; Stucki D; Buser M; Obrecht JP
Schweiz Med Wochenschr; 1983 Dec; 113(50):1908-11. PubMed ID: 6229873
[TBL] [Abstract][Full Text] [Related]
32. Vaccine failure in malnourished animals: use of a bioimmunomodulator to improve immunocompetence.
Ghoshal D; Barua AK; Roy SK; Bhattacharrya H
Nutrition; 1990; 6(2):153-7. PubMed ID: 2134528
[TBL] [Abstract][Full Text] [Related]
33. Assessment of host immune response in breast cancer patients.
Akimoto M; Ishii H; Nakajima Y; Iwasaki H; Tan M; Abe R; Kasai M
Cancer Detect Prev; 1986; 9(3-4):311-7. PubMed ID: 3488806
[TBL] [Abstract][Full Text] [Related]
34. A trial of human alpha interferon as an adjuvant agent in breast cancer after loco-regional recurrence.
Fentiman IS; Balkwill FR; Cuzick J; Hayward JL; Rubens RD
Eur J Surg Oncol; 1987 Oct; 13(5):425-8. PubMed ID: 3666158
[TBL] [Abstract][Full Text] [Related]
35. [Immunotherapy of cancer--status and perspectives].
Mey U
Z Gesamte Inn Med; 1987 Jan; 42(1):18-20. PubMed ID: 3577263
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer among atomic bomb survivors--the relationship of prognosis to pathologic findings.
Tokunaga M
Acta Pathol Jpn; 1979 Mar; 29(2):197-209. PubMed ID: 552793
[TBL] [Abstract][Full Text] [Related]
37. Effects of glycyrrhizae and glycyrrhizic acid on cellular immunocompetence in low-dose gamma-ray irradiated mice.
Lin IH; Hau DM; You JS; Huang HF; Chen KT; Chiou YY
Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):370-7. PubMed ID: 10584407
[TBL] [Abstract][Full Text] [Related]
38. [Immunotherapy of cancer using levamisole, immunologic control of the post-surgical patient and graphic follow-up].
de Carli HO; Llargues JM
Rev Esp Oncol; 1980; 27(1):67-80. PubMed ID: 7209109
[TBL] [Abstract][Full Text] [Related]
39. A new orthotopic model of human breast cancer in immunocompetent rats.
Akla B; Monteil J; Paraf F; Sturtz F; Rigaud M
Anticancer Res; 2003; 23(5A):3761-6. PubMed ID: 14666675
[TBL] [Abstract][Full Text] [Related]
40. Immunostimulation by propionibacteria--effects on immune status and antineoplastic treatment.
Isenberg J; Stoffel B; Wolters U; Beuth J; Stützer H; Ko HL; Pichlmaier H
Anticancer Res; 1995; 15(5B):2363-8. PubMed ID: 8572653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
